NCT02533453 A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients. Status COMPLETED Phase PHASE4
NCT02532998 A Study to Assess the Pharmacodynamic Effect of Single Doses of AZD9977 in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02532309 A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques Status UNKNOWN Phase PHASE4
NCT02531165 Platelet Inhibition After Pre-hospital Ticagrelor Using Fentanyl Compared to Morphine in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Status COMPLETED Phase NA
NCT02530411 Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer Status UNKNOWN Phase PHASE2
NCT02527434 Study of Tremelimumab in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE2
NCT02524808 Prospective Identification and Validation of "BRCANess" Profile in Ovarian Epithelial Cancer Status UNKNOWN Phase N/A
NCT02520518 Does Dapagliflozin Promote Favorable Health Benefits That Are Independent Of Weight Loss? Status TERMINATED Phase PHASE2
NCT02516241 Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02512575 A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567. Status COMPLETED Phase PHASE1
NCT02511795 AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT02511106 AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy. Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02504346 AZD9291, an Irreversible EGFR-TKI, in Relapsed EGFR-mutated Non-small Cell Lung Cancer Patients Previously Treated With an EGFR-TKI, Coupled to Extensive Translational Studies Status UNKNOWN Phase PHASE2
NCT02503436 C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population Status COMPLETED Phase N/A